BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37809195)

  • 1. Fertility and Obstetric Outcomes of Assisted Reproductive Technology (ART) in Women With Adenomyosis Following Gonadotropin-Releasing Hormone Agonist Therapy: A Single-Center Experience.
    Rao AR; Duraikannan UP; Rao DR; Giridhar P; Chinnasamy SN
    Cureus; 2023 Sep; 15(9):e44691. PubMed ID: 37809195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J; Wu Y; Wu Z; Wu Y; Yang R; Liu Y; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study.
    Chen M; Luo L; Wang Q; Gao J; Chen Y; Zhang Y; Zhou C
    Front Endocrinol (Lausanne); 2020; 11():318. PubMed ID: 32547490
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.
    Zhang L; Cai H; Liu X; Xiong Y; Liang X; Shi J
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):946. PubMed ID: 36528566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of uterine malformations on pregnancy and neonatal outcomes of IVF/ICSI-frozen embryo transfer.
    Qiu J; Du T; Chen C; Lyu Q; Mol BW; Zhao M; Kuang Y
    Hum Reprod; 2022 Mar; 37(3):428-446. PubMed ID: 35048124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment.
    Thalluri V; Tremellen KP
    Hum Reprod; 2012 Dec; 27(12):3487-92. PubMed ID: 22997247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ovarian stimulation protocols on outcomes of assisted reproductive technology in adenomyosis women: a retrospective cohort study.
    Ge L; Li Y; Guan S; Cui L; Chen ZJ
    Front Endocrinol (Lausanne); 2023; 14():1198779. PubMed ID: 37664864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET)].
    Tao T; Chen S; Chen X; Ye D; Xu L; Tian X; Liu Y; Niu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):248-51. PubMed ID: 25736122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment.
    Hou X; Xing J; Shan H; Mei J; Sun Y; Yan G; Sun H; Wang J
    Reprod Biomed Online; 2020 Nov; 41(5):845-853. PubMed ID: 32972873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.
    Pan D; Yang J; Zhang N; Wang L; Li N; Shi J; Zhou H
    Reprod Biol Endocrinol; 2022 Feb; 20(1):26. PubMed ID: 35115007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bicornuate uterus on pregnancy and obstetric outcomes of in vitro fertilization / intracytoplasmic sperm injection.
    Kong WY; Zhao SR; Deng K; Zhang Q; Liu W; Yan L
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():132-138. PubMed ID: 33421810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer.
    Wang Y; Yi YC; Guu HF; Chen YF; Kung HF; Chang JC; Chen LY; Chuan ST; Chen MJ
    Sci Rep; 2023 Apr; 13(1):6741. PubMed ID: 37185812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis.
    Wu Y; Huang J; Zhong G; Lan J; Lin H; Zhang Q
    Reprod Biomed Online; 2022 Feb; 44(2):380-388. PubMed ID: 34895827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
    Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
    Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fresh versus frozen embryo transfers in assisted reproduction.
    Zaat T; Zagers M; Mol F; Goddijn M; van Wely M; Mastenbroek S
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011184. PubMed ID: 33539543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.